Lohmann & Rauscher (L&R) is expanding its expertise and product range in the field of customised medical procedure trays with the acquisition of the German Angiokard Medizintechnik GmbH, a portfolio company of DMB. L&R is thus strengthening its market position in the international hospital sector.
Angiokard Medizintechnik GmbH has been producing and distributing customised trays for cardiology, anaesthesia, angiography, cardiac surgery and intensive care since its foundation in 1986. With more than 30 years of experience in the industry, the German company with 132 employees and headquarters in Friedeburg/Lower Saxony is a recognised supplier, particularly in Germany, where it has a strong market position.
The multi-component medical procedure trays are produced in Germany in an economical and quality-assured manner and are put together according to requirements – type of operation and specific customer needs – and thus ensure efficient hospital processes.
“This acquisition is another important milestone on our successful path as a strong player in the hospital market and a reliable solution provider for our customers. Angiokard’s high-quality products are an optimal addition to our existing portfolio in the area of customised medical procedure trays under the Kitpack® brand. Together with Angiokard’s extensive expertise in production, logistics and distribution, we have the ideal basis for further dynamic growth in our core business area of set systems & hygiene,” said Wolfgang Süßle, President, CEO, CCO and Chairman of the Management Board of the L&R Group.
Peter Welge, Managing Director of DMB (Deutsche Mittelstand Beteiligungen GmbH) commented: “We are proud to have sustainably developed Angiokard together with the management into a champion in the manufacturing of sets for angiography and cardiology over the past ten years. With the sale to Lohmann & Rauscher, we have found an excellent new home and a strong strategic partner for Angiokard. Thanks to the flexible, long-term investment approach, DMB was once again able to realise an investment with a very positive development of the company and value.”
DMB is a Hamburg-based investment company focusing on majority equity investments in medium-sized companies in German-speaking countries with sales between EUR 10 and 50 million.
Carlsquare acted as the exclusive financial advisor to DMB and Angiokard.
